American Capital Advisory’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8K | Buy |
716
+12
| +2% | +$432 | 0.01% | 240 |
|
|
2025
Q1 | $21.9K | Buy |
704
+4
| +0.6% | +$125 | 0.01% | 255 |
|
|
2024
Q4 | $17.9K | Hold |
700
| – | – | 0.01% | 262 |
|
|
2024
Q3 | $19.8K | Sell |
700
-200
| -22% | -$5.66K | 0.01% | 250 |
|
|
2024
Q2 | $25.3K | Sell |
900
-100
| -10% | -$2.81K | 0.02% | 201 |
|
|
2024
Q1 | $36K | Buy |
1,000
+100
| +11% | +$3.6K | 0.03% | 162 |
|
|
2023
Q4 | $25.3K | Buy |
+900
| New | +$25.3K | 0.02% | 201 |
|